Lineage Therapeutics Inc

FDA Filings

This page includes the latest FDA filings for Lineage Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device Company	Device	Date
Albendazole Lineage Therapeutics Inc	Prescription Medication	2020-12-30
Albendazole Lineage Therapeutics Inc	Prescription Medication	2019-04-18
HYDROCORTISONE Lineage Therapeutics Inc	Prescription Medication	2018-12-11
Dextroamphetamine Sulfate Lineage Therapeutics Inc	Prescription Medication	2018-12-08
NDC 54505-055 Lineage Therapeutics Inc	Albendazole	2018-09-24
NDC 54505-333 Lineage Therapeutics Inc	HYDROCORTISONE	2007-03-30
NDC 54505-332 Lineage Therapeutics Inc	HYDROCORTISONE	2007-03-30
NDC 54505-331 Lineage Therapeutics Inc	HYDROCORTISONE	2007-03-30
NDC 54505-329 Lineage Therapeutics Inc	Dextroamphetamine Sulfate	1976-08-02
NDC 54505-328 Lineage Therapeutics Inc	Dextroamphetamine Sulfate	1976-08-02
NDC 54505-327 Lineage Therapeutics Inc	Dextroamphetamine Sulfate	1976-08-02

Similar & Related FDA Registered Companies

Related Finance Registrations

NCAGE Code	6YRT8	LINEAGE THERAPEUTICS INC.
CAGE Code	6YRT8	LINEAGE THERAPEUTICS INC.
DUNS	078677620	Lineage Therapeutics Inc.

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.